131 related articles for article (PubMed ID: 15826263)
1. Editorial comment: Operation and failure.
Ovadia M
Pacing Clin Electrophysiol; 2005 Apr; 28(4):301-3. PubMed ID: 15826263
[No Abstract] [Full Text] [Related]
2. The problem of orphan procedures: Comment on "sudden cardiac death complicating alcohol septal ablation: a case report and review of literature".
Tobis J
Catheter Cardiovasc Interv; 2009 Jun; 73(7):960. PubMed ID: 19455562
[No Abstract] [Full Text] [Related]
3. [On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)].
Schwab J; Bareiter T; Bär I; Gottwik M
Z Kardiol; 2003 Sep; 92(9):763. PubMed ID: 14508595
[No Abstract] [Full Text] [Related]
4. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
5. Can septal myectomy prevent sudden cardiac death in hypertrophic obstructive cardiomyopathy?
Efthimiadis GK; Meditskou S; Mezilis NE; Styliadis I; Manthos A; Parcharidis GE
Eur Heart J; 2007 Sep; 28(17):2177; author reply 2177-8. PubMed ID: 17670761
[No Abstract] [Full Text] [Related]
6. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
[No Abstract] [Full Text] [Related]
7. Implantable defibrillators in hypertrophic cardiomyopathy.
Grace A
Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
[No Abstract] [Full Text] [Related]
8. Treating hypertrophic cardiomyopathy: two views.
Salberg L
J Am Coll Cardiol; 2005 Dec; 46(11):2146; author reply 2146-7. PubMed ID: 16325059
[No Abstract] [Full Text] [Related]
9. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: Clinicopathological correlations. Can J Cardiol 2001;17:197-202.
Tyers GF
Can J Cardiol; 2001 Oct; 17(10):1099. PubMed ID: 11706838
[No Abstract] [Full Text] [Related]
10. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
Maron BJ
Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
[No Abstract] [Full Text] [Related]
11. [Diagnosis and treatment of hypertrophic cardiomyopathies].
Kühl C; Luedde M; Langer C; Frey N
Dtsch Med Wochenschr; 2013 Mar; 138(12):583-8. PubMed ID: 23483418
[TBL] [Abstract][Full Text] [Related]
12. Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you.
Nishimura RA; Ommen SR
Circ Cardiovasc Interv; 2010 Apr; 3(2):91-3. PubMed ID: 20407109
[No Abstract] [Full Text] [Related]
13. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
[No Abstract] [Full Text] [Related]
14. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Raj SR; Mitchell LB; Sheldon RS
N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
[No Abstract] [Full Text] [Related]
15. Lessons from the failure and recall of an implantable cardioverter-defibrillator.
Hauser RG; Maron BJ
Circulation; 2005 Sep; 112(13):2040-2. PubMed ID: 16172264
[No Abstract] [Full Text] [Related]
16. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
[No Abstract] [Full Text] [Related]
17. Sudden death in hypertrophic cardiomyopathy.
Watkins H
N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
[No Abstract] [Full Text] [Related]
18. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
19. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
Cotiga D; Ehlert F; Sherrid M
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hypertrophic cardiomyopathy.
Penas-Lado M; Barriales-Villa R; Monserrat L
Circulation; 2003 Apr; 107(16):e110; auhor reply e110. PubMed ID: 12719296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
